Comparaisons Financières Royalty Pharma plc

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 09/07/2026			Varia. 5j.	Varia. 1 janv.
57,96 ^USD	-0,70%		+0,33%	+50,00%

09/06	Transcript : Royalty Pharma plc Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 04:00 PM
09/06	GSK s'offre le spécialiste de l'oncologie Nuvalent pour 10,6 milliards de dollars	AN

Secteur:

Région:

Axe X:

Principaux concurrents

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Chiffre d'affaires (Y-1)	Marge nette (Y-1)	Marge EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
ROYALTY PHARMA PLC	3,25 Md	23,69%	91,15%	27,16%	14,4%	2.81x
ELI LILLY AND COMPANY	65,18 Md	31,67%	41,84%	106,69%	22,77%	1.2x
JOHNSON & JOHNSON	94,19 Md	28,46%	32,23%	31,68%	13,82%	0.84x
ABBVIE INC.	61,16 Md	6,91%	38,79%	64 669,09%	13,22%	2.44x
ROCHE HOLDING AG	77,58 Md	20,94%	35,49%	47,65%	15,43%	0.66x
ASTRAZENECA PLC	58,74 Md	17,41%	31,46%	31,99%	13,12%	1.2x
NOVARTIS AG	56,67 Md	24,64%	38,62%	38,4%	16,33%	1.02x
NOVO NORDISK A/S	48,59 Md	33,14%	41,3%	60,7%	20,31%	0.69x
AMGEN INC.	36,75 Md	20,98%	44,09%	162,88%	12,98%	2.13x
GILEAD SCIENCES, INC.	29,44 Md	28,9%	44,81%	48,87%	17,34%	1.08x
PFIZER INC.	62,58 Md	12,42%	35,11%	21,07%	8,73%	1.79x
VERTEX PHARMACEUTICALS INCORPORATED	12 Md	32,94%	43,85%	27,07%	16,41%	-1.21x
BRISTOL-MYERS SQUIBB COMPANY	48,19 Md	14,64%	30,37%	72,08%	7,72%	1.83x
GSK PLC	43,97 Md	17,5%	29,95%	46,39%	9,48%	1.28x
SANOFI	51,22 Md	17,91%	27,85%	10,5%	6,02%	0.81x
CHUGAI PHARMACEUTICAL CO., LTD.	8,02 Md	34,5%	47,6%	22,1%	25,56%	-0.66x
BAYER AG	53,51 Md	-7,94%	11,21%	16,66%	-3,36%	4.79x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	28,34 Md	4,26%	9,07%	-2,1%	1,29%	-3.38x
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	4,52 Md	24,4%	28,42%	14,26%	12,85%	-4.14x
ALNYLAM PHARMACEUTICALS, INC.	3,71 Md	8,45%	13,51%	73,28%	6,82%	-0.38x
Moyenne	42,38 Md	19,79%	35,84%	3 276,32%	12,56%	0,74x
Moyenne pondérée par Capi.	59,43 Md	23,44%	37,23%	6 373,7%	15,78%	1,08x